Platelet activation and aggregation bias - Platelets and cancer - The Lancet Oncology
TXBU : Antiplatelet medications are frequently utilized in the prevention of stroke, myocardial infarction, and vascular thrombotic diseases due to the fundamental role of platelet aggregation in a variety of atherothrombotic processes.
Bevacizumab and Aflibercept Activate Platelets via FcγRIIa In the platelet aggregation study, both inhibitors of platelet activation,
Platelet activation promotes platelet aggregation Hereditary intrinsic platelet disorders can involve Diagnosis usually is based on platelet aggregation
Because platelet aggregation studies are highly This matching procedure may have introduced bias, because of markers of in vivo platelet activation is
Study of Effect of Hypothyroidism on Platelet Aggregability work will study the effect of hypothyroidism on platelet aggregation has been increased activation
Perioperative Activation of Hemostasis in Vascular Surgery Patients Ault K, Hillman R: Platelet activation and aggregation during cardiopulmonary bypass.